The biopharmaceuticals SPAC was co-founded by CEO Dr. Clive Meanwellis. CFO Chris Visioli, who previously worked for The Medicines Company, in that role raised over $300 million in outside capital and co-managed the global business development process which resulted in the sale of the company to Novartis AG for $9.7 billion in January. Read more.
Related Posts
RedBall Files Investor Presentation on SeatGeek Deal
RedBall is a $575 million SPAC, sponsored by an affiliate of RedBird Capital Partners under the control of “MoneyBall” figure Billy Beane.
TradeUP Adds $10M PIPE to Support Estrella 7 Weeks After Shareholders Approve Deal
Hefty redemptions have delayed the deal closing, with trading now expected to begin next month.
Media and Entertainment Focused Iron Horse Acquisitions Files for $100M IPO
Iron Horse in the S-1 filing said it intends to search globally for target companies within the M&E industry with a primary focus on the United States.
Aries I Acquisition Liquidates
The balance of the trust as of March 8 was approximately $24 million. The SPAC had raised $125 million in a May 2021 IPO, although redemptions ahead of several extension votes whittled down the trust over the last 22 months.